$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
A DOS approach for quantitatively assessing radiation skin toxicities using optical biomarkers has been presented. Visual skin toxicity scoring systems require expert training and even then are prone to inter-observer variability and subjectivity. The DOS system and analysis software is simple to use, requires minimal training and returns objective functional parameters for interpreting physiological changes in skin. Furthermore, instead of describing the appearance of a skin lesion as a single parameter, DOS provides a wealth of information in spectral shape, optical properties and functional / microstructural parameters that offer an added degree of sensitivity and specificity not available in current qualitative scoring methods. Sections 1 and 7 highlight the main processing steps for obtaining absolute spectral data that can be utilized for quantitative fitting of optical biomarkers. Background and baseline subtraction are vital to allow the user to perform the DOS measurements under normal lighting conditions. Section 8 provides the necessary models and equations needed to describe athymic mice before and after x-ray irradiation. Here, the choice of appropriate absorbers is vital for an accurate description of the measured spectra. It is advised that the user thoroughly investigate in the literature the key absorbers that dominate the wavelength range and tissue of interest used in a given study prior to constructing an optical biomarker fitting model. Finally, Sections 3-5 describe the handling of the athymic mice during DOS acquisition. To avoid disrupting the local vasculature, use gentle force to place the DOS probe on the mouse skin surface.
While relatively inexpensive compared to hyperspectral camera systems3,4, a clear limitation of the described DOS approach is the use of a point probe for measuring diffuse reflectance. This reflectance geometry necessities gentle contact with the skin and has the potential to introduce measurement uncertainty by dispersing the vasculature if consistent probe-skin pressure is not employed. Future designs of the DOS probe may incorporate a pressure sensor to maintain consistent results. Further, while the use of close source-detector separation (< 2-3 mm) allows for optical probing depths specific to the skin surface, the improved specificity comes at a loss of spatial resolution compared to 2D hyperspectral imaging. To minimize this limitation, a 5 point quadrant scan that captures the overall irradiated volume was employed. Despite the lack of spatial resolution, previous work in mice5 has shown the ability of optical biomarkers averaged over a sparse area to differentiate not only irradiated and non-irradiated skin but also the impact of skin sparing interventional drugs such as Vasculotide6.
It should be noted that while the overall system design can be modified for different skin models, the underlying basis spectra and scattering shape may need to be optimized. Specifically, while oxy- and deoxy-Hb well describe an athymic mouse model, the application of the same model to darker skin may require the addition of melanin for optimal fitting. In addition, extension of the DOS bandwidth to higher wavelengths > 950 nm would necessitate the addition of water, which dominates at higher wavelengths. Furthermore, animal models with different skin thicknesses may require a different source-detector separation to optimize depth sensitivity. Lastly, the hairless feature makes algorithms simpler. Although non-hairless models may be optimal for certain research questions, they will require hair removal before DOS measurements, and skin irritation from this process may affect results. For research where total immune function is crucial, an immunocompetent hairless mouse (e.g., SKH-1) may serve as a better model due to its euthymic nature.
Important considerations for DOS probe measurements are consistent RT and estimation of the irradiated area. Temperature fluctuations can affect tissue Hb and StO2 levels. Measuring a group of 3 non-irradiated animals at each data collection time may serve as a baseline to which unintended environmental fluctuations in parameter values can be normalized. Additionally, the irradiated area may be difficult to estimate (if skin flap preparations were not consistent) before damage begins to manifest visually around day 5 (40 Gy). If using black permanent marker to dot the boundaries of the radiation-exposed skin, avoid excessive ink use to prevent ink smudging, which can compromise readings.
An added feature of the system is the ability to separate absorption from scattering properties. While alternative hyperspectral imaging systems also provide the ability to monitor oxyHb and Hb concentration, the free-space geometry of hyperspectral imaging is unable to resolve scattering changes. This limitation may result in inaccuracies in the returned oxyHb, Hb and StO2 parameters if significant changes in scattering occur due to erythema (redness). Further, monitoring of scattering changes using DOS may provide additional optical biomarkers for erythema evaluation. As shown in Figure 6, the initial results from Yohan et al. (2014) indicate that A and k demonstrate a temporal trend following ionizing radiation that does not correlate with trends observed from other alternative methods such as visual scoring systems. This indicates that scattering changes do not manifest in a visually descriptive manner and may in fact be describing a separate biological process. Therefore, compared to alternative methods, DOS provides a high resolution for superficial scattering changes, an avenue for investigating novel skin damage biomarkers that may be separate from the usual Hb-based measurements.
Although our model employs a large single radiation dose (rather than multiple small fractionated doses that are used in the clinical setting), this mimics the pathophysiology of acute human skin radiotoxicity21. It is envisioned that with further optimization, DOS may provide a quantitative approach for automated and standardized scoring of radiation induced skin reactions. After mastering this technique, future applications may include monitoring differences between skin sparing therapeutics (e.g., comparing oxyHb levels between a control and experimental treatment for skin radioprotection, or for wound healing promotion). While ideal for high-throughput drug screening in animal models, the DOS system is potentially adaptable to the clinical environment due to ease of usability and the ability to measure in normal lighting conditions. In this case, the probe design may require minor modifications with slightly larger optode separations to account for the increased thickness of human skin. A clinical DOS system would allow for on-line evaluation of interventional therapies that could minimize painful skin reactions and improve patient comfort and compliance. In the future, it may be interesting to expand DOS-based quantification to the features of chronic radiation induced skin damage (e.g., fibrosis).